Search results
Analyst Thinks This Company's Bone Marrow Cancer Treatment Can 'Transform Paradigm'
Benzinga via Yahoo Finance· 2 years agoSVB Leerink initiated coverage on CTI Biopharma Corp (NASDAQ: CTIC) with an Outperform rating and a...
Has CTI BioPharma (CTIC) Outpaced Other Medical Stocks This Year?
Zacks via Yahoo Finance· 1 year agoFor those looking to find strong Medical stocks, it is prudent to search for companies in the group...
BSO presents Gala-ctic celebration of sci-fi in music and dress
The Herald-Times via Yahoo News· 2 years agoThree opportunities are coming to see and hear the Bloomington Symphony Orchestra: matinee and...
CTI BioPharma (CTIC) Reports Q2 Loss, Tops Revenue Estimates
Zacks via Yahoo Finance· 2 years agoCTI BioPharma (CTIC) delivered earnings and revenue surprises of -5% and 20.87%, respectively, for...
Will CTI BioPharma (CTIC) Report Negative Earnings Next Week? What You Should Know
Zacks via Yahoo Finance· 1 year agoCTI BioPharma (CTIC) doesn't possess the right combination of the two key ingredients for a likely...
CTI BioPharma Corp. (NASDAQ:CTIC) Q4 2022 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 year agoCTI BioPharma Corp. (NASDAQ:CTIC) Q4 2022 Earnings Call Transcript March 6, 2023 Operator: Good...
European Swedish Orphan Biovitrum To Acquire CTI BioPharma For $1.7B
Benzinga via Yahoo Finance· 12 months agoSwedish Orphan Biovitrum AB (OTC: BIOVF) has agreed to acquire CTI BioPharma (NASDAQ: CTIC) for...
12 Best Multibagger Stocks to Buy Now
Insider Monkey via Yahoo Finance· 1 year agoIn this article, we discuss 12 best multibagger stocks to buy now. If you want to see more stocks in this selection, check out 5 Best Multibagger Stocks...
Why CTI Biopharma Stock Is Surging Today
Motley Fool· 2 years agoShares of CTI BioPharma (NASDAQ: CTIC) moved sharply higher after the drugmaker reported first-quarter results Friday morning. Investors were pleased...
CTI BioPharma: Q1 Earnings Snapshot
AP Finance via Yahoo Finance· 12 months agoSEATTLE (AP) — SEATTLE (AP) — CTI BioPharma Corp. (CTIC) on Monday reported a loss of $13.4 million in its first quarter. The Seattle-based company said it had a loss of 10 cents per share.